跳至主要内容
临床试验/NCT01141127
NCT01141127已完成2 期

Tranexamic Acid (TXA) During Pediatric Cardiac Surgery: A Prospective Randomised Study Comparing Two Dosing Regimens

Centre Chirurgical Marie Lannelongue1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
18
试验地点
1
主要终点
Preoperative plasma tranexamic acid concentration is measured using high performance liquid chromatography

研究概览

简要总结

The purpose of this study is to determine tranexamic acid plasma levels in children undergoing cardiac surgery at risk of bleeding and to compare two dosing regimens.

详细描述

Tranexamic acid (TXA) is administered intravenously to prevent bleeding associated with cardiac surgery and by pass in adult and children. The pharmacokinetic of this product is unknown in the pediatric population. Only a few studies report a clinical efficacy with different dosages. The purpose of this study is to determine the plasma level of TXA using two different administrations methods: continuous versus intermittent. The second objective is to determine whether fibrinolysis decreased. The population consists in children weighting 10 to 30 Kilos, undergoing cardiac surgery and at high risk of bleeding.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
12 Months 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • children weighing between 10 and 30kg surgery with cardiopulmonary bypass for congenital heart disease deemed hemorrhagic

排除标准

  • the patients undergoing a surgical procedure short and simple
  • patients with past history of convulsions neurologiques especially allergies to the TA
  • patients with renal insufficiency

研究组 & 干预措施

INTERMITENT ADMINISTRATION

Active Comparator

Administration of 10 mg/kg of Tranexamic Acid at the beginning ,the middle and at the end of the intervention

干预措施: Tranexamic Acid (Drug)

continuous administration of Tranexamic Acid

Experimental

Administration of 10 mg /Kg of Tranexamic Acid at the beginning in the priming pump and continuous infusion of 1 mg/KG of Tranexamic Acid until the end of the intervention

干预措施: Tranexamic Acid (Drug)

结局指标

主要结局

Preoperative plasma tranexamic acid concentration is measured using high performance liquid chromatography

时间窗: Blood samples are collected during the operative period within 24 hours

次要结局

  • preoperative plasma tranexamic acid concentration is measured using high performance liquid chromatography(blood samples collected during the operative period within the first 24 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Tranexamic Acid (TXA) in Pediatric Cardiac Surgery | 临床试验